Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins.

  • Read more about Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins.

Environmental Exposures Influence Fetal Brain Growth and Risk of Neonatal Brain Injury in Congenital Heart Disease.

  • Read more about Environmental Exposures Influence Fetal Brain Growth and Risk of Neonatal Brain Injury in Congenital Heart Disease.

Evaluation of a Rapid Immunoassay for Molecular Subphenotype Classification in Pediatric Acute Cardiorespiratory Failure.

  • Read more about Evaluation of a Rapid Immunoassay for Molecular Subphenotype Classification in Pediatric Acute Cardiorespiratory Failure.

Wearable-derived Sleep Measurements are Associated with Long-COVID in the RECOVER Adult Cohort.

  • Read more about Wearable-derived Sleep Measurements are Associated with Long-COVID in the RECOVER Adult Cohort.

The Role of Trusted Adults in Shaping Adolescent Health Information Access and Mental Wellbeing in Urban India.

  • Read more about The Role of Trusted Adults in Shaping Adolescent Health Information Access and Mental Wellbeing in Urban India.

Multicohort assessment of plasma metabolic signatures of tuberculosis disease in children.

  • Read more about Multicohort assessment of plasma metabolic signatures of tuberculosis disease in children.

Methods for Preserving Cellular and Milk Fat Globules RNA from Human Milk Samples.

  • Read more about Methods for Preserving Cellular and Milk Fat Globules RNA from Human Milk Samples.

Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.

  • Read more about Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.

FocaL mass drug Administration for Plasmodium vivax Malaria Elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru.

  • Read more about FocaL mass drug Administration for Plasmodium vivax Malaria Elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru.

Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype.

  • Read more about Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype.

Pagination

  • Page 1
  • Next page ››
Subscribe to Research square

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List